Literature DB >> 11751424

IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1.

M T Lin1, C Y Juan, K J Chang, W J Chen, M L Kuo.   

Abstract

Apoptosis plays a critical role in maintaining genomic integrity by selectively removing the most heavily damaged cells from the population. Reactive oxygen species (ROS) and certain inflammatory cytokines are always elevated during the human carcinogenic process. However, the biological significance of the interplay between ROS and inflammatory cytokine remains elusive. This study demonstrates that interleukin-6 (IL-6) effectively protects gastric cancer cells from the apoptosis induced by hydrogen peroxide (H(2)O(2)). The cell death signaling JNK pathway elicited by H(2)O(2) is also inhibited by IL-6. We further found that Mcl-1, but not other Bcl-2 family members, was up-regulated by IL-6, by a substantial level over 24 h. We further transfected a mcl-1 expression vector, pCMV-mcl-1, into the AGS cells, and successfully obtained several mcl-1-overexpressing clones. Flow cytometric analysis shows that these mcl-1-overexpressing AGS cells are more resistant to the apoptosis induced by H(2)O(2) when compared with the neo control AGS cells. Consistently, the activation of the JNK pathway induced by H(2)O(2) is also blocked in mcl-1-overexpressed cells. These results indicate that the anti-apoptotic effect of IL-6 is, at least in part, due to the up-regulation of mcl-1. To our surprise, either IL-6 exposure or mcl-1 overexpression fails to reduce the level of intracellular peroxides in the AGS cells triggered by H(2)O(2). This study also determined the level of 8-hydroxydeoxyguanosine (8-OH-dGua), an indicator for oxidative DNA lesions in IL-6-treated or mcl-1-overexpressed AGS cells after treatment with H(2)O(2). Notably, our results indicate that a majority of the 8-OH-dGua is efficiently removed in the AGS cells without IL-6 treatment, whereas only approximately 50% of the 8-OH-dGua was repaired in the IL-6-treated AGS cells after 24 h. Similarly, approximately 60-70% of the 8-OH-dGua also failed to repair and was retained in the genomic DNA of the mcl-1 transfectants. Results in this study provide a novel mechanism by which up-regulation of the Mcl-1 protein by IL-6 may enhance the susceptibility to H(2)O(2)-induced oxidative DNA lesions by overriding apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751424     DOI: 10.1093/carcin/22.12.1947

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  34 in total

1.  Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.

Authors:  Uddalak Bharadwaj; Christian Marin-Muller; Min Li; Changyi Chen; Qizhi Yao
Journal:  Carcinogenesis       Date:  2011-04-23       Impact factor: 4.944

2.  Gene expression profile of compressed primary human cementoblasts before and after IL-1β stimulation.

Authors:  Katja Diercke; Sebastian Zingler; Annette Kohl; Christopher J Lux; Ralf Erber
Journal:  Clin Oral Investig       Date:  2014-01-10       Impact factor: 3.573

3.  Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.

Authors:  Yan Liu; Pui-Kai Li; Chenglong Li; Jiayuh Lin
Journal:  J Biol Chem       Date:  2010-06-18       Impact factor: 5.157

4.  Mechanisms of alcohol-induced hepatocellular carcinoma.

Authors:  Sreetha Sidharthan; Shyam Kottilil
Journal:  Hepatol Int       Date:  2014-09       Impact factor: 6.047

Review 5.  Roles for inflammation and regulatory T cells in colon cancer.

Authors:  Susan E Erdman; Theofilos Poutahidis
Journal:  Toxicol Pathol       Date:  2009-12-17       Impact factor: 1.902

6.  SPARC ameliorates ovarian cancer-associated inflammation.

Authors:  Neveen A Said; Ahmed A Elmarakby; John D Imig; David J Fulton; Kouros Motamed
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

7.  Increased oxidative DNA damage, inducible nitric oxide synthase, nuclear factor kappaB expression and enhanced antiapoptosis-related proteins in Helicobacter pylori-infected non-cardiac gastric adenocarcinoma.

Authors:  Chi-Sen Chang; Wei-Na Chen; Hui-Hsuan Lin; Cheng-Chung Wu; Chau-Jong Wang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 8.  Role of interleukin-6 in cancer progression and therapeutic resistance.

Authors:  Neeraj Kumari; B S Dwarakanath; Asmita Das; Anant Narayan Bhatt
Journal:  Tumour Biol       Date:  2016-06-03

9.  Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.

Authors:  Angela DeMichele; Robert Gray; Michelle Horn; Jinbo Chen; Richard Aplenc; William P Vaughan; Martin S Tallman
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

10.  Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.

Authors:  Fanyin Meng; Yoko Yamagiwa; Yoshiyuki Ueno; Tushar Patel
Journal:  J Hepatol       Date:  2005-12-13       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.